Shiga, Yuji
Nezu, Tomohisa http://orcid.org/0000-0003-4877-2336
Shimomura, Ryo
Sato, Kota
Himeno, Takahiro
Terasawa, Yuka
Aoki, Shiro
Hosomi, Naohisa
Kohriyama, Tatsuo
Maruyama, Hirofumi
Funding for this research was provided by:
Japan Society for the Promotion of Science KAKENHI (20K16579)
Article History
Received: 15 August 2021
Accepted: 19 November 2021
First Online: 1 December 2021
Declarations
:
: Dr. Maruyama received Grants-in-Aid for Scientific Research (20K07887) and research support from Eisai, Pfizer, Takeda Pharmaceutical, Otsuka Pharmaceutical, Nihon Pharmaceutical, Shionogi, Teijin Pharma, Fuji Film, Sumitomo Dainippon Pharma, Nihon Medi-Physics, Bayer, MSD, Daiichi Sankyo, Kyowa Hakko Kirin, Sanofi, Novartis, Kowa Pharmaceutical, Astellas Pharma, Tsumura, and Japan Blood Products Organization, which are unrelated to the submitted work. All other authors declare that they have no conflict of interest.
: This study complied with the Declaration of Helsinki for investigations involving humans, and the study protocol was approved by the Ethics Committee of the Brain Attack Center Ota Memorial Hospital (217).
: The requirement for informed consent was waived by the ethics committee considering the retrospective, noninterventional nature of the study.
: The data that support the findings of this study are available from the corresponding author on reasonable request.
: Not applicable.
: Not applicable.
: Not applicable.